Crohn's disease, TNF-α, and the leaky gut. The chicken or the egg?

American Journal of Gastroenterology

Volumn 97, Issue 8, 2002, Pages 1867-1868

  Hollander, Daniel ^a,b  

^a Broad Medical Research Program   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

CROHN DISEASE; DISEASE ACTIVITY; EDITORIAL; ENTERITIS; IMMUNE RESPONSE; INTESTINE MUCOSA PERMEABILITY; PRIORITY JOURNAL; TH1 CELL;

EID: 0036677473     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04252-1     Document Type: Editorial

References (19)

1. Changes in the incidence of inflammatory bowel disease: What does it mean?
2. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease
3. Increased intestinal permeability in Crohn's patients and their relatives: An etiological factor
4. Tumor necrosis factor: Biology and therapeutic inhibitors
5. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor-α for Crohn's disease
6. Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease
7. Tumour necrosis factor alpha and interleukin 1 beta in relapse of Crohn's disease
8. Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immune-PCR
9. Permeability in Crohn's disease. Altered barrier functions in healthy relatives?
10. Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-alpha
11. Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line
12. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis
13. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease
14. Anti-TNF-α therapy of rheumatoid arthritis: What have we learned?
15. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis
16. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6
17. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
18. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
19. TGF-α/Smad signaling defects in inflammatory bowel disease: Mechanisms and possible novel therapies for chronic inflammation